STOCK TITAN

KLA Corporation (KLAC) Form 4 Filings

KLAC NASDAQ

Here are the Form 4 insider transactions from KLA Corporation (KLAC) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow KLAC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KLAC filings page.

Rhea-AI Summary

KLA CORP President and CEO Richard P. Wallace sold 4,512 shares of common stock in an open-market transaction at $1,794 per share on May 12, 2026. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on November 19, 2025, indicating it was scheduled in advance rather than timed opportunistically.

After this transaction, Wallace directly holds 75,895.008 shares of KLA common stock. This figure includes 57,511.168 shares issuable upon vesting of restricted stock units, so a large portion of his exposure remains tied to equity-based compensation.

Rhea-AI Summary

KLA CORP senior executive Virendra A. Kirloskar, the SVP & Chief Accounting Officer, reported an open-market sale of common stock. On May 11, 2026, he sold 297 shares of KLA common stock at $1,879.02 per share. After this transaction, he reports owning 1,957.491 shares directly, and a footnote explains this figure includes 1,951.639 shares issuable upon vesting of restricted stock units (RSUs).

Rhea-AI Summary

KLA CORP director Jeneanne Michelle Hanley reported an open-market sale of company stock. On May 11, 2026, she sold 550 shares of KLA common stock in the open market at a weighted average price of $1,874.706 per share, with individual sale prices ranging from $1,874.64 to $1,875.08.

After this transaction, Hanley directly holds 3,550.732 shares of KLA common stock, which includes 203.732 shares issuable upon vesting of restricted stock units (RSUs). This filing reflects a relatively small net sale compared with her remaining direct holdings and shows no associated option exercises or derivative transactions in this report.

Rhea-AI Summary

KLA Corp director Robert Calderoni reported a small equity award. On February 5, 2026, he received a grant of restricted stock units for 11.269 shares of KLA common stock at no cost. These RSUs vest on the earliest of February 5, 2027, immediately before the next annual stockholder meeting, or ten days before a change of control of KLA.

After this grant, Calderoni directly beneficially owns 3,700.971 shares of KLA common stock, which includes 267.971 shares issuable upon vesting of RSUs. He also indirectly beneficially owns 11,529.527 shares held by The 2019 Calderoni Family Trust, where he serves as trustee and beneficiary.

Rhea-AI Summary

KLA Corp executive Bren D. Higgins, EVP & Chief Financial Officer, reported a planned stock sale. On 12/16/2025, he sold 2,254 shares of KLA common stock at $1,237.01 per share in an open market transaction coded as a sale.

The filing states this sale was carried out under a Rule 10b5-1 trading plan adopted on May 5, 2025, which is designed to pre-arrange trades. After this transaction, Higgins beneficially owned 32,154.4 shares of KLA common stock, including 21,418.468 shares issuable upon vesting of restricted stock units.